Valacyclovir Dosing for Pediatric Patients with Chickenpox

Dosage and Administration

• For a 20kg pediatric patient with chickenpox, the recommended dose is 400 mg per dose, three times daily, according to Praxis Medical Insights 1
• The total daily dose for a 20kg pediatric patient with chickenpox is 1,200 mg, as recommended by the MMWR Recommendations and Reports 2

Treatment Guidelines

• The Centers for Disease Control and Prevention emphasizes that treatment is most effective when started early in the disease course, with valacyclovir offering the advantage of less frequent dosing, as noted by Praxis Medical Insights 3
• The CDC recommends acyclovir as the preferred first-line agent for chickenpox in children, with a dosage of 20 mg/kg orally, maximum 800 mg/dose, 4 times daily for 7-10 days, according to MMWR Recommendations and Reports 2

Patient Care

• Ensure adequate hydration throughout the treatment course with valacyclovir, as advised by Praxis Medical Insights 1
• Valacyclovir does not eradicate latent virus or affect the risk of future recurrences, as stated by Praxis Medical Insights 3

Monitoring and Adverse Effects

• Watch for clinical improvement within 48-72 hours of initiating valacyclovir therapy, and monitor for neutropenia with prolonged use, though this is uncommon with standard 5-day courses, as recommended by Praxis Medical Insights 1